Paper II
2019 July (Supplementary) (2010 Scheme)

Question

Third generation / Fourth generation cephalosporins in MRSA infection

Q140.3 marksShort Answers

Answer

Chosen drug: Fourth-generation cephalosporins (relatively preferred of the two, with an important caveat)

Justification: Fourth-generation cephalosporins (e.g., cefepime) have a broader Gram-positive spectrum than third-generation agents, but neither third- nor fourth-generation cephalosporins reliably cover MRSA (methicillin-resistant Staphylococcus aureus) — MRSA resistance is due to an altered penicillin-binding protein (PBP2a) that most beta-lactams, including standard cephalosporins, cannot bind effectively. If forced to choose between only these two, fourth-generation agents have marginally better Gram-positive activity, but the actual drug of choice for MRSA infection is Vancomycin (or Linezolid, or fifth-generation Ceftaroline, which specifically retains affinity for PBP2a) — none of which were among the given options.

Other Years Asked


Revise MBBS
Preview